2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Hepatitis C Virus Infection: new trials by email Literature Review of Hepatitis C Virus Infection trials Research Report on Hepatitis C Virus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection SOF/VEL/VOX - Hepatitis C Virus Infection | Phase 2 | Terminated | Gilead Sciences | 21 | 2019-01-28 | 2020-10-23 |
| Safety and Efficacy Study in Hepatitis C Patients With PHN121 PHN121 - Hepatitis C Virus Infection | Phase 1 / Phase 2 | Terminated | PhytoHealth Corporation | 12 | 2009-09-01 | 2013-11-26 |
Hepatitis C (2)
Blood-Borne Infections (2) · Communicable Diseases (2) · Digestive System Diseases (2) · Flaviviridae Infections (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Infections (2) · Liver Diseases (2) · RNA Virus Infections (2) · Virus Diseases (2)
sofosbuvir velpatasvir voxilaprevir drug combination (1)
Gilead Sciences (1) · PhytoHealth Corporation (1)
Italy (1) · Poland (1) · Taiwan (1) · United Kingdom (1)
Chia-Yen Dai, M.D., M.S. (1) · Ming-Lung Yu, M.D., Ph.D. (1) · Wan-Long Chuang, M.D., Ph.D. (1)
2018 (1)